Cytoplasmic Aggregation of RPB1 Predicts Failure of Neoadjuvant Chemotherapy
B. Nagy-Miko, O. Nemeth-Szatmari, R. Farago-Meszaros, A. Csokasi, B. Bognar, N. Ördög, B. N. Borsos, H. Majoros, Z. Ujfaludi, O. Olah-Nemeth, A. Nikolenyi, A. Dobi, R. Koszo, D. Santha, G. Lazar, , A. Vörös
The paper shows that cytoplasmic RPB1 aggregation in biopsy samples predicts poor response to neoadjuvant chemotherapy in invasive carcinoma patients.
bioRxiv · Jan 13, 2023 · PreprintCancer Biology